Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data

Mary E. Wylie, Mark D. Miller, M. Katherine Shear, John T. Little, Benoit H. Mulsant, Bruce G. Pollock, Charles F. Reynolds

Research output: Contribution to journalArticle

Abstract

The authors present data from an open trial of fluvoxamine (median daily dosage: 200 mg) in the treatment of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder in 19 older outpatients (mean age = 66.8). Of the 12 subjects completing the 21-week trial, 8 achieved a good response (50% reduction in symptom measures) and 7 were rated as much or very much improved. Fluvoxamine pharmacotherapy also had a significant effect in reducing comorbid depressive symptoms and in increasing levels of functioning. These data support the effectiveness of fluvoxamine in older subjects with anxiety disorders (particularly generalized anxiety disorder) and warrant further double-blind, placebo-controlled evaluation.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalJournal of Geriatric Psychiatry and Neurology
Volume13
Issue number1
StatePublished - 2000

Fingerprint

Fluvoxamine
Anxiety Disorders
Drug Therapy
Panic Disorder
Obsessive-Compulsive Disorder
Outpatients
Placebos
Depression
Therapeutics

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Geriatrics and Gerontology
  • Neuroscience(all)

Cite this

Wylie, M. E., Miller, M. D., Shear, M. K., Little, J. T., Mulsant, B. H., Pollock, B. G., & Reynolds, C. F. (2000). Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data. Journal of Geriatric Psychiatry and Neurology, 13(1), 43-48.

Fluvoxamine pharmacotherapy of anxiety disorders in later life : Preliminary open-trial data. / Wylie, Mary E.; Miller, Mark D.; Shear, M. Katherine; Little, John T.; Mulsant, Benoit H.; Pollock, Bruce G.; Reynolds, Charles F.

In: Journal of Geriatric Psychiatry and Neurology, Vol. 13, No. 1, 2000, p. 43-48.

Research output: Contribution to journalArticle

Wylie, ME, Miller, MD, Shear, MK, Little, JT, Mulsant, BH, Pollock, BG & Reynolds, CF 2000, 'Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data', Journal of Geriatric Psychiatry and Neurology, vol. 13, no. 1, pp. 43-48.
Wylie ME, Miller MD, Shear MK, Little JT, Mulsant BH, Pollock BG et al. Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data. Journal of Geriatric Psychiatry and Neurology. 2000;13(1):43-48.
Wylie, Mary E. ; Miller, Mark D. ; Shear, M. Katherine ; Little, John T. ; Mulsant, Benoit H. ; Pollock, Bruce G. ; Reynolds, Charles F. / Fluvoxamine pharmacotherapy of anxiety disorders in later life : Preliminary open-trial data. In: Journal of Geriatric Psychiatry and Neurology. 2000 ; Vol. 13, No. 1. pp. 43-48.
@article{1d7a3ddb663e4f0ab92ce0089a43b8ce,
title = "Fluvoxamine pharmacotherapy of anxiety disorders in later life: Preliminary open-trial data",
abstract = "The authors present data from an open trial of fluvoxamine (median daily dosage: 200 mg) in the treatment of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder in 19 older outpatients (mean age = 66.8). Of the 12 subjects completing the 21-week trial, 8 achieved a good response (50{\%} reduction in symptom measures) and 7 were rated as much or very much improved. Fluvoxamine pharmacotherapy also had a significant effect in reducing comorbid depressive symptoms and in increasing levels of functioning. These data support the effectiveness of fluvoxamine in older subjects with anxiety disorders (particularly generalized anxiety disorder) and warrant further double-blind, placebo-controlled evaluation.",
author = "Wylie, {Mary E.} and Miller, {Mark D.} and Shear, {M. Katherine} and Little, {John T.} and Mulsant, {Benoit H.} and Pollock, {Bruce G.} and Reynolds, {Charles F.}",
year = "2000",
language = "English (US)",
volume = "13",
pages = "43--48",
journal = "Journal of Geriatric Psychiatry and Neurology",
issn = "0891-9887",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Fluvoxamine pharmacotherapy of anxiety disorders in later life

T2 - Preliminary open-trial data

AU - Wylie, Mary E.

AU - Miller, Mark D.

AU - Shear, M. Katherine

AU - Little, John T.

AU - Mulsant, Benoit H.

AU - Pollock, Bruce G.

AU - Reynolds, Charles F.

PY - 2000

Y1 - 2000

N2 - The authors present data from an open trial of fluvoxamine (median daily dosage: 200 mg) in the treatment of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder in 19 older outpatients (mean age = 66.8). Of the 12 subjects completing the 21-week trial, 8 achieved a good response (50% reduction in symptom measures) and 7 were rated as much or very much improved. Fluvoxamine pharmacotherapy also had a significant effect in reducing comorbid depressive symptoms and in increasing levels of functioning. These data support the effectiveness of fluvoxamine in older subjects with anxiety disorders (particularly generalized anxiety disorder) and warrant further double-blind, placebo-controlled evaluation.

AB - The authors present data from an open trial of fluvoxamine (median daily dosage: 200 mg) in the treatment of generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder in 19 older outpatients (mean age = 66.8). Of the 12 subjects completing the 21-week trial, 8 achieved a good response (50% reduction in symptom measures) and 7 were rated as much or very much improved. Fluvoxamine pharmacotherapy also had a significant effect in reducing comorbid depressive symptoms and in increasing levels of functioning. These data support the effectiveness of fluvoxamine in older subjects with anxiety disorders (particularly generalized anxiety disorder) and warrant further double-blind, placebo-controlled evaluation.

UR - http://www.scopus.com/inward/record.url?scp=0034007618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034007618&partnerID=8YFLogxK

M3 - Article

C2 - 10753007

AN - SCOPUS:0034007618

VL - 13

SP - 43

EP - 48

JO - Journal of Geriatric Psychiatry and Neurology

JF - Journal of Geriatric Psychiatry and Neurology

SN - 0891-9887

IS - 1

ER -